Re: Diethylstilbesterol revisited: androgen deprivation, osteoporosis an prostate cancer.
Pitts
W Reid
WR
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000819:agonists* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009919:Orchiectomy; D010024:Osteoporosis / Q000139:chemically induced* / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; D007987:Gonadotropin-Releasing Hormone; D004054:Diethylstilbestrol